GLP-1 Receptor Agonists Improve Outcomes After Major Limb Events in Diabetes: Study
Taiwan: Researchers have found in a nationwide cohort of patients with diabetes and a history of major adverse limb events that treatment with GLP-1 receptor agonists was associated with significantly…